Production of Human IFN? Protein in Nicotiana benthamiana Plant through an Enhanced Expression System Based on Bamboo mosaic Virus.

ABSTRACT: Plant-based systems are safe alternatives to the current platforms for the production of biologically active therapeutic proteins. However, plant-based expression systems face certain major challenges, including the relatively low productivity and the generation of target proteins in biologically active forms. The use of plant virus-based expression systems has been shown to enhance yields, but further improvement is still required to lower the production cost. In this study, various strategies were employed to increase the yields of an important therapeutic protein, human interferon gamma (IFN?), in Nicotiana benthamiana through modifications of expression vectors based on potexviruses. Among these, the vector based on a coat protein (CP)-deficient Bamboo mosaic virus (BaMV), pKB?CHis, was shown to exhibit the highest expression level for the unmodified IFN?. Truncation of the N-terminal signal peptide of IFN (designated mIFN?) resulted in a nearly seven-fold increase in yield. Co-expression of a silencing suppressor protein by replacing the coding sequence of BaMV movement protein with that of P19 led to a 40% increase in mIFN? accumulation. The fusion of endoplasmic reticulum (ER) retention signal with mIFN? significantly enhanced the accumulation ratio of biologically active dimeric mIFN? to 87% relative to the non-active monomeric form. The construct pKB19mIFN?ER, employing the combination of all the above enhancement strategies, gave the highest level of protein accumulation, up to 119 ± 0.8 ?g/g fresh weight, accounting for 2.5% of total soluble protein (TSP) content. These findings advocate the application of the modified BaMV-based vector as a platform for high-level expression of therapeutic protein in N. benthamiana.

SUBMITTER: Jiang MC 

PROVIDER: S-EPMC6630494 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature